serascience limited

0.5

serascience limited Company Information

Share SERASCIENCE LIMITED
Live 
EstablishedDeclining

Company Number

07591669

Registered Address

york biotech campus sand hutton, york, YO41 1LZ

Industry

Manufacture of medical and dental instruments and supplies

 

Telephone

01865339494

Next Accounts Due

March 2025

Group Structure

View All

Directors

Chris Yates7 Years

Shareholders

abingdon health plc 100%

serascience limited Estimated Valuation

£0

Pomanda estimates the enterprise value of SERASCIENCE LIMITED at £0 based on a Turnover of £0 and 0.84x industry multiple (adjusted for size and gross margin).

serascience limited Estimated Valuation

£0

Pomanda estimates the enterprise value of SERASCIENCE LIMITED at £0 based on an EBITDA of £-2.4k and a 5.23x industry multiple (adjusted for size and gross margin).

serascience limited Estimated Valuation

£0

Pomanda estimates the enterprise value of SERASCIENCE LIMITED at £0 based on Net Assets of £-3.3m and 2.3x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Serascience Limited Overview

Serascience Limited is a live company located in york, YO41 1LZ with a Companies House number of 07591669. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in April 2011, it's largest shareholder is abingdon health plc with a 100% stake. Serascience Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Serascience Limited Health Check

Pomanda's financial health check has awarded Serascience Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating0.5out of 5
positive_score

0 Strong

positive_score

1 Regular

positive_score

4 Weak

size

Size

There is insufficient data available for this Key Performance Indicator!

- - Serascience Limited

- - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (6.2%)

- - Serascience Limited

- - Industry AVG

production

Production

There is insufficient data available for this Key Performance Indicator!

- - Serascience Limited

- - Industry AVG

profitability

Profitability

There is insufficient data available for this Key Performance Indicator!

- - Serascience Limited

- - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (86)

- - Serascience Limited

- - Industry AVG

paystructure

Pay Structure

on an average salary of £46.8k, the company has an equivalent pay structure (£46.8k)

- - Serascience Limited

- - Industry AVG

efficiency

Efficiency

There is insufficient data available for this Key Performance Indicator!

- - Serascience Limited

- - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Serascience Limited

- - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Serascience Limited

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Serascience Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (12 weeks)

- - Serascience Limited

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 9909.3%, this is a higher level of debt than the average (44%)

- - Serascience Limited

- - Industry AVG

SERASCIENCE LIMITED financials

EXPORTms excel logo

Serascience Limited's latest turnover from June 2023 is 0 and the company has net assets of -£3.3 million. According to their latest financial statements, Serascience Limited has 2 employees and maintains cash reserves of £33.3 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Dec 2017Dec 2016Dec 2015Dec 2014Oct 2013Apr 2013Apr 2012
Turnover024,36799,445208,932503,026362,223465,460945,077408,1521,002,045370,938594,588209,182
Other Income Or Grants0000000000000
Cost Of Sales75033,619141,249126,014307,234223,803280,727550,356233,416584,123224,040354,833124,104
Gross Profit-750-9,252-41,80482,918195,792138,420184,733394,721174,737417,921146,898239,75585,078
Admin Expenses1,6185,6824,687333,795448,737331,341771,230965,935810,400959,516548,927410,466214,189
Operating Profit-2,368-14,934-46,491-250,877-252,945-192,921-586,497-571,214-635,663-541,595-402,029-170,711-129,111
Interest Payable097,20097,20097,217203,700178,502142,65483,84428,7750000
Interest Receivable04300405319342672029941,418663551
Pre-Tax Profit-1,477-112,091-143,691-348,094-456,240-371,104-728,810-654,991-664,236-540,601-400,611-170,048-128,560
Tax000163000000000
Profit After Tax-1,477-112,091-143,691-347,931-456,240-371,104-728,810-654,991-664,236-540,601-400,611-170,048-128,560
Dividends Paid0000000000000
Retained Profit-1,477-112,091-143,691-347,931-456,240-371,104-728,810-654,991-664,236-540,601-400,611-170,048-128,560
Employee Costs93,69687,28488,635116,674216,038274,716363,932358,948234,247305,996105,393178,04971,459
Number Of Employees2222579968352
EBITDA*-2,368-12,804-45,923-215,201-207,774-170,779-543,321-534,952-542,368-430,243-394,361-169,355-129,022

* Earnings Before Interest, Tax, Depreciation and Amortisation

Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Dec 2017Dec 2016Dec 2015Dec 2014Oct 2013Apr 2013Apr 2012
Tangible Assets000036710,22714,86023,33015,01834,77745,5126,9890
Intangible Assets002,1302,698205,355240,666253,754315,910269,789338,469219,159116,6994,161
Investments & Other0000000000000
Debtors (Due After 1 year)0000000000000
Total Fixed Assets002,1302,698205,722250,893268,614339,240284,807373,246264,671123,6884,161
Stock & work in progress0017,088108,322122,494164,051189,890120,69814,21313,4259,12000
Trade Debtors0032,331053,6113,8796,426173,4360203,60325,15545,5998,570
Group Debtors0000000000000
Misc Debtors01889,59425,104136,304304,282230,097275,450185,3100000
Cash33,26932,64846,39320,70893,98914,001113,67922,96730,46050,384347,02044,877220,315
misc current assets0000000000000
total current assets33,26932,836105,406154,134406,398486,213540,092592,551229,983267,412381,29590,476228,885
total assets33,26932,836107,536156,832612,120737,106808,706931,791514,790640,658645,966214,164233,046
Bank overdraft0000000000000
Bank loan0000000000000
Trade Creditors 001,79513,444109,0128,67521,988133,5817,095173,535188,242227,672100,506
Group/Directors Accounts3,295,416001,930,466000000000
other short term finances0000000000000
hp & lease commitments0000000000000
other current liabilities1,3012,079,8072,040,6214,11126,41929,84925,869102,71369,4110000
total current liabilities3,296,7172,079,8072,042,4161,948,021135,43138,52447,857236,29476,506173,535188,242227,672100,506
loans0001,215,0003,134,9472,900,6002,591,7631,797,601885,3970000
hp & lease commitments0000000000000
Accruals and Deferred Income0000000000000
other liabilities01,215,0001,215,000000000250,000035,00011,000
provisions0000000000000
total long term liabilities01,215,0001,215,0001,215,0003,134,9472,900,6002,591,7631,797,601885,397250,000035,00011,000
total liabilities3,296,7173,294,8073,257,4163,163,0213,270,3782,939,1242,639,6202,033,895961,903423,535188,242262,672111,506
net assets-3,263,448-3,261,971-3,149,880-3,006,189-2,658,258-2,202,018-1,830,914-1,102,104-447,113217,123457,724-48,508121,540
total shareholders funds-3,263,448-3,261,971-3,149,880-3,006,189-2,658,258-2,202,018-1,830,914-1,102,104-447,113217,123457,724-48,508121,540
Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Dec 2017Dec 2016Dec 2015Dec 2014Oct 2013Apr 2013Apr 2012
Operating Activities
Operating Profit-2,368-14,934-46,491-250,877-252,945-192,921-586,497-571,214-635,663-541,595-402,029-170,711-129,111
Depreciation0003679,8604,6339,7789,90510,09722,0247,1342910
Amortisation02,13056835,30935,31117,50933,39826,35783,19889,3285341,06589
Tax000163000000000
Stock0-17,088-91,234-14,172-41,557-25,83969,192106,4857884,3059,12000
Debtors-188-41,73716,821-164,811-118,24671,638-212,363263,576-18,293178,44816,58537,0298,570
Creditors0-1,795-11,649-95,568100,337-13,313-111,593126,486-166,440-14,70787,736127,166100,506
Accruals and Deferred Income-2,078,50639,1862,036,510-22,308-3,4303,980-76,84433,30269,4110000
Deferred Taxes & Provisions0000000000000
Cash flow from operations-2,080,68683,4122,053,351-153,93148,936-225,911-588,587-745,225-621,892-627,703-332,330-79,218-37,086
Investing Activities
capital expenditure000167,3480-4,42127,450-90,695-4,856-219,927-268,178-120,883-4,250
Change in Investments0000000000000
cash flow from investments000167,3480-4,42127,450-90,695-4,856-219,927-268,178-120,883-4,250
Financing Activities
Bank loans0000000000000
Group/Directors Accounts3,295,4160-1,930,4661,930,466000000000
Other Short Term Loans 0000000000000
Long term loans00-1,215,000-1,919,947234,347308,837794,162912,204885,3970000
Hire Purchase and Lease Commitments0000000000000
other long term liabilities-1,215,00001,215,00000000-250,000250,000-11,00024,00011,000
share issue000000000300,000736,7950250,100
interest0-97,157-97,200-97,217-203,295-178,183-142,312-83,777-28,5739941,418663551
cash flow from financing2,080,416-97,157-2,027,666-86,69831,052130,654651,850828,427606,824550,994727,21324,663261,651
cash and cash equivalents
cash621-13,74525,685-73,28179,988-99,67890,712-7,493-19,924-296,636126,705-175,438220,315
overdraft0000000000000
change in cash621-13,74525,685-73,28179,988-99,67890,712-7,493-19,924-296,636126,705-175,438220,315

serascience limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for serascience limited. Get real-time insights into serascience limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Serascience Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for serascience limited by selecting its closest rivals, whether from the MANUFACTURING sector, other established companies, companies in YO41 area or any other competitors across 12 key performance metrics.

serascience limited Ownership

SERASCIENCE LIMITED group structure

Serascience Limited has no subsidiary companies.

Ultimate parent company

1 parent

SERASCIENCE LIMITED

07591669

SERASCIENCE LIMITED Shareholders

abingdon health plc 100%

serascience limited directors

Serascience Limited currently has 1 director, Mr Chris Yates serving since Aug 2017.

officercountryagestartendrole
Mr Chris YatesEngland50 years Aug 2017- Director

P&L

June 2023

turnover

0

-100%

operating profit

-2.4k

-84%

gross margin

null%

%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2023

net assets

-3.3m

0%

total assets

33.3k

+0.01%

cash

33.3k

+0.02%

net assets

Total assets minus all liabilities

serascience limited company details

company number

07591669

Type

Private limited with Share Capital

industry

32500 - Manufacture of medical and dental instruments and supplies

incorporation date

April 2011

age

13

incorporated

UK

ultimate parent company

accounts

Full Accounts

last accounts submitted

June 2023

previous names

N/A

accountant

-

auditor

BDO LLP

address

york biotech campus sand hutton, york, YO41 1LZ

Bank

-

Legal Advisor

-

serascience limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to serascience limited.

charges

serascience limited Companies House Filings - See Documents

datedescriptionview/download